Automation and High-Throughput Technologies

Primary Cell 3D Pancreatic Cancer Organoid Models for Phenotypic High-throughput Therapeutic Screening

Monday, February 5
11:30 AM - 12:00 PM
Location: 6F

Pancreatic cancer remains a leading cause of cancer-associated death, with a median survival of ~ 6 months and 5-year survival rate less than 8%. The tumor microenvironment promotes tumor initiation and progression, and is associated to cancer metastasis and drug resistance. Traditional high throughput screening (HTS) assays for drug discovery use lab adapted 2D monolayer cancer cell models, which inadequately recapitulate the physiologic context of cancer. Primary cell 3D cell culture models have recently received renewed recognition not only due to their ability to better mimic the complexity of in vivo tumors but, are now cost effective and efficient. Here we describe phenotypically relevant 3D cell culture in ultra-low-attachment high density 384 and 1536 well plates using a magnetic force-based bioprinting technology. We have validated HTS amenable 2D and 3D spheroid/organoid-based cytotoxicity assays using 4 pancreatic cancer-associated cell lines against 5 known anti-cancer agents, and thereby screened ~3,400 drugs from Approved Drug and National Cancer Institute (NCI) collections. Assay quality was notable with Z’ averaging >0.8 across all assays and cell lines. As anticipated, results from the 3D screen were significantly different from the parallel screen performed on 2D cell monolayers. Collectively, these data indicate that a complex 3D cell culture can be adapted for quantitative HTS and may improve the disease relevance of assays used for therapeutic screening. Further analysis provides a basis for expedited translation into clinical study due to their well-known pharmacology in humans.

Shurong Hou

Postdoctoral fellow
The Scripps Research Institute Molecular Screening Center

Pharmaceutical Sciences, HTS

Presentation(s):

Send Email for Shurong Hou


Assets

Primary Cell 3D Pancreatic Cancer Organoid Models for Phenotypic High-throughput Therapeutic Screening



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Primary Cell 3D Pancreatic Cancer Organoid Models for Phenotypic High-throughput Therapeutic Screening